The Fianna Fáil leader Michael Martin has confirmed to the Mica Action Group that his party will insist on a redress for affected homeowners to be included as a line item in the upcoming budget. Members of MIG travelled to Leinster house to have a face to face meeting with Micheál Martin, Charlie Mc Conalogue and Darragh O’ Brien to discuss the inclusion of a redress scheme for homeowners affected by defective blocks in the upcoming Budget.The Mica Action Group is a voluntary group formed in early 2014 by individuals whose own homes are cracking due to defective blocks. Hundreds of homes across Donegal are believed to be affected by Mica.Member Michael Doherty said “MAG welcomed the invite from Micheál Martin to meet with him, Charlie and Darragh face to face to discuss the issue of defective blocks in Donegal.“In particular MAG took the opportunity to impress on the delegation the significant influence Fianna Fáil has on the budget outcome and their role in ensuring this issue is allocated a line item in the upcoming budget.“We also asked for the protocol review process to be expedited, finalised and published with immediate effect. “We explained how time is of the essence and that we needed to see action now to address the dire situation homeowners are finding themselves in.“Micheál Martin confirmed a number of times that he will ‘insist’ on the inclusion of redress in the budget. Charlie Mc Conalogue also recognised the importance of concluding the protocol development and review process and assured MAG of is continued support in this regard.”The group said they are encouraged by this outcome and were further heartened to hear how up-to-speed Micheál was in respect of this issue and thanked Charlie for his continued support in bringing this to the attention of the Fianna Fail leadership team.“We also took the opportunity to invite Micheál to Donegal to meet with homeowners and to see for himself, the very difficult circumstances and stress homeowners are facing.“MAG see this as a further step in the fight for redress and look forward to the publication of the budget with anticipation and increased optimism.” The Mica Action Group is a voluntary group formed in early 2014 by individuals whose own homes are cracking due to defective blocks.The objective of the group is to seek redress for homeowners affected by this issue.The group has engaged with government on a local and on a national level to determine the exact scale and the cause of the problem in the county.Fianna Fail to insist on Mica Redress scheme in Budget 2019 was last modified: September 27th, 2018 by StephenShare this:Click to share on Facebook (Opens in new window)Click to share on Twitter (Opens in new window)Click to share on LinkedIn (Opens in new window)Click to share on Reddit (Opens in new window)Click to share on Pocket (Opens in new window)Click to share on Telegram (Opens in new window)Click to share on WhatsApp (Opens in new window)Click to share on Skype (Opens in new window)Click to print (Opens in new window)Tags:fianna failMIGredress scheme
April 13, 6-8 p.m.University of North Carolina-Wilmington, McNeill Hall Lecture Hall, 601 S. College Rd., Wilmington April 5, 4-6 p.m.Southwestern Community College Myers Auditorium, 447 College Dr., Sylva April 6, 12-2 p.m. Holiday Inn Express, 1943 Blowing Rock Rd., Boone April 7, 6:30-8:30 p.m.Guilford County Health and Human Services, 1203 Maple St., Greensboro April 6, 6:30-8:30 p.m.Asheville-Buncombe Technical Community College, Mission Health /A-B Tech Conference Center, 340 Victoria Rd., Asheville People with disabilities who need assistance to participate in the public hearings are requested to notify the Division of Health Benefits at 919-855-3470 in advance so accommodations can be arranged.In addition to submitting comments online and at public hearings, written comments may be submitted by email to [email protected]; by U.S. Mail to Division of Health Benefits, North Carolina Department of Health and Human Services, 2501 Mail Service Center, Raleigh, NC 27699-2501; or in person at the North Carolina Department of Health and Human Services, 101 Blair Drive, Adams Building, Raleigh, N.C.Visit the N.C. Medicaid Reform website at www.ncdhhs.gov/nc-medicaid-reform for more details and updates.About N.C. Medicaid ReformN.C. Medicaid Reform is the result of nearly three years of public engagement and planning, and is an important step in accomplishing the joint vision of Governor Pat McCrory and the N.C. General Assembly. The Medicaid Reform plan will achieve better patient care, better community health, improved doctor-patient engagement and cost containment.Medicaid covers nearly two million North Carolina citizens at an annual cost of $13 billion to the state and the federal government. It serves approximately one in five North Carolinians, and covers about 55 percent of births in the state. About 80,000 health care providers in the state serve Medicaid clients. March 31, 6:30-8:30 p.m.Central Piedmont Community College, Merancas Campus Auditorium,11930 Verhoeff Dr., Huntersville April 8, 2-4 p.m.Forsyth County Department of Public Health, Meeting Room 1 & 2, 799 North Highland Ave., Winston-Salem The North Carolina Department of Health and Human Services is receiving public comments through April 18, 2016, on the draft N.C. Medicaid reform waiver application. Public feedback is important to shape the final application before it is submitted June 1, 2016, to the federal Centers for Medicare & Medicaid Services.The public is able to submit comments online using the N.C. Medicaid Reform website atwww.ncddhs.gov/nc-medicaid-reform, or at one of 12 public hearings planned across the state. Dates and locations for the public hearings are below:March 30, 6-8 p.m.McKimmon Center, Room 6, 1101 Gorman St., Raleigh April 14, 2-4 p.m.Greenville Convention Center, Emerald Ballroom, 303 SW Greenville Blvd., Greenville April 16, 10 a.m.-12 p.m.College of The Albemarle, AE 208, 1208 N. Road St., Elizabeth City April 18, 3:30-5:30 p.m.University of North Carolina-Pembroke, Moore Hall Auditorium, 1 University Dr., Pembroke March 31, 2-4 p.m.Union County Department of Social Services, Auditorium,1212 W. Roosevelt Blvd., Monroe
Designer protein halts flu Eva-Maria Strauch By Robert F. ServiceJun. 12, 2017 , 11:15 AM There’s a new weapon taking shape in the war on flu, one of the globe’s most dangerous infectious diseases. Scientists have created a designer protein that stops the influenza virus from infecting cells in culture and protects mice from getting sick after being exposed to a heavy dose of the virus. It can also be used as a sensitive diagnostic. And although it isn’t ready as a treatment itself, the protein may point the way to future flu drugs, scientists say.“It’s impressive,” says James Crowe, an immunologist at Vanderbilt University in Nashville, who was not involved in the study. But because it hasn’t yet been tested in humans, “it [still] has a long way to go,” he says.Influenza severely sickens 3–5 million people each year, and it kills between 250,000 and 500,000, mostly the elderly and people with weakened immune systems. Every year, public health officials survey the three flu subtypes circulating in humans and design a vaccine for the next winter season that covers them all. But those vaccines are far from perfect: They don’t always exactly match the viruses actually going around, and in some people, the shots fail to trigger a vigorous immune response.Sign up for our daily newsletterGet more great content like this delivered right to you!Country *AfghanistanAland IslandsAlbaniaAlgeriaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBolivia, Plurinational State ofBonaire, Sint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCambodiaCameroonCanadaCape VerdeCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos (Keeling) IslandsColombiaComorosCongoCongo, The Democratic Republic of theCook IslandsCosta RicaCote D’IvoireCroatiaCubaCuraçaoCyprusCzech RepublicDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEthiopiaFalkland Islands (Malvinas)Faroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island and Mcdonald IslandsHoly See (Vatican City State)HondurasHong KongHungaryIcelandIndiaIndonesiaIran, Islamic Republic ofIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKorea, Democratic People’s Republic ofKorea, Republic ofKuwaitKyrgyzstanLao People’s Democratic RepublicLatviaLebanonLesothoLiberiaLibyan Arab JamahiriyaLiechtensteinLithuaniaLuxembourgMacaoMacedonia, The Former Yugoslav Republic ofMadagascarMalawiMalaysiaMaldivesMaliMaltaMartiniqueMauritaniaMauritiusMayotteMexicoMoldova, Republic ofMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorwayOmanPakistanPalestinianPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalQatarReunionRomaniaRussian FederationRWANDASaint Barthélemy Saint Helena, Ascension and Tristan da CunhaSaint Kitts and NevisSaint LuciaSaint Martin (French part)Saint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint Maarten (Dutch part)SlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwazilandSwedenSwitzerlandSyrian Arab RepublicTaiwanTajikistanTanzania, United Republic ofThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkeyTurkmenistanTurks and Caicos IslandsTuvaluUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVenezuela, Bolivarian Republic ofVietnamVirgin Islands, BritishWallis and FutunaWestern SaharaYemenZambiaZimbabweI also wish to receive emails from AAAS/Science and Science advertisers, including information on products, services and special offers which may include but are not limited to news, careers information & upcoming events.Required fields are included by an asterisk(*)Drugs are another line of defense. Most focus on the proteins on the virus’s outer coat, neuraminidase and hemagglutinin (HA). Some drugs that block neuraminidase, which helps the virus escape already infected cells, are starting to bump up against viral resistance. HA is scientists’ next target. The mushroom-shaped protein specializes in infecting cells, first by binding a trio of sites on its head to three separate sugar molecules on the surface of targeted cells. Once the virus latches on, parts of HA’s stem act as a grappling hook to pull the virus in close, allowing it to fuse with the cell membrane and release its contents inside.In 2011, researchers led by David Baker, a computational biologist at the University of Washington in Seattle, created a designer protein that binds HA’s stem, which prevented viral infection in cell cultures. But because the stem is often shrouded by additional protein, it can be hard for drugs to reach it.Now, Baker’s team has designed proteins to target HA’s more exposed head group. They started by analyzing x-ray crystal structures that show in atomic detail how flu-binding antibodies in people grab on to the three sugar-binding sites on HA’s head. They copied a small portion of the antibody that wedges itself into one of these binding sites. They then used protein design software called Rosetta to triple that head-binding section, creating a three-part, triangular protein, which the computer calculated would fit like a cap over the top of HA’s head group. Next, they synthesized a gene for making the protein and inserted it into bacteria, which cranked out copies for them to test.In the test, Baker’s team immobilized copies of the protein on a paperlike material called nitrocellulose. They then exposed it to different strains of the virus, which it grabbed and held. “We call it flu glue, because it doesn’t let go,” Baker says. In other experiments, the protein blocked the virus from infecting cells in culture, and it even prevented mice from getting sick when administered either 1 day before or after viral exposure, they report today in Nature Biotechnology.Despite these early successes, Baker and Crowe caution that the newly designed protein isn’t likely to become a medicine itself. For starters, Baker says, the protein doesn’t bind all flu strains that commonly infect humans. That means a future drug may require either a cocktail of HA head group binding proteins or work in combination with stem-binding versions. Second, the safety of designer proteins will have to be studied carefully, Crowe says, because they are markedly different than natural HA-binding antibodies. “The further you get away from a natural antibody, the less you can predict what will happen,” Crowe says.But down the road, Baker says, the new designer protein could serve as the basis for a cheap diagnostic—akin to a pregnancy test—for detecting flu and possibly even medicines able to knock it out. A designer protein (brown and orange) fits snugly on top of the influenza virus’s hemagglutinin protein (green), which helps the virus latch onto and infect cells.